Physician

Brian Jin So, M.D.

According to 2025 Medicare claims, Brian So, M.D. (NPI: 1841499100) practices gastroenterology in the Texarkana, TX-AR market, with the plurality of this provider's patient population coming from Bowie, TX. This provider's primary affiliated billing organization is TEXARKANA GASTROENTEROLOGY CONSULTANTS, PA (NPI: 1477519056; TIN: 752572296) and primary practice location at 75503-4660.

So's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 812 traditional Medicare patients, billed 19,113 HCPCS/CPT codes, and received $639,859 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 2,804 prescription claims across 914 beneficiaries totaling $1,905,048 in drug costs, led by Epclusa (Sofosbuvir/Velpatasvir). 2023 DME data shows 12 claims. Open Payments data shows 137 records totaling $2,383. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $121,953 to $639,859. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $320,286 and ending at $1,905,048. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	476	1,131	$121,953
2016	826	1,741	$191,177
2017	769	1,512	$164,091
2018	720	1,534	$176,606
2019	677	4,641	$232,139
2020	601	8,863	$317,789
2021	749	18,871	$489,305
2022	754	13,188	$561,664
2023	698	11,859	$467,300
2024	812	19,113	$639,859

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	252	618	$320,286
2016	558	1,740	$1,031,859
2017	605	2,206	$1,552,797
2018	666	2,550	$1,398,979
2019	643	2,401	$1,231,545
2020	551	2,291	$1,119,617
2021	656	2,351	$1,208,197
2022	667	2,431	$952,300
2023	685	2,315	$899,885
2024	914	2,804	$1,905,048

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$98
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	184	186	$194
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	225	316	$89
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	112	114	$68
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	197	1,329	$47
99439	Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month	195	2,309	$36

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Epclusa	Sofosbuvir/Velpatasvir	11	308	$270,368
Xifaxan	Rifaximin	55	1,282	$157,398
Creon	Lipase/Protease/Amylase	29	1,074	$114,822
Entyvio	Vedolizumab	12	672	$100,414
Rinvoq	Upadacitinib	11	330	$77,588

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	137	$2,383	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian Jin So, M.D.?

Tedicare shows public-source Medicare data for Brian Jin So, M.D. (NPI 1841499100), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian Jin So, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brian Jin So, M.D.?

Brian Jin So, M.D. is linked to TEXARKANA GASTROENTEROLOGY CONSULTANTS, PA (billing NPI 1477519056) in the available physician profile data.

Does Brian Jin So, M.D. have Open Payments data?

Brian Jin So, M.D. has 137 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.